Aprea Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	21	18	18	62	104	963
Market Cap Growth	119.26%	0.11%	-71.52%	-40.90%	-89.18%	-
Enterprise Value	-12	-4	-11	9	16	834
PE Ratio	-	-1.23	-0.16	-1.66	-1.95	-34.33
PS Ratio	21.41	30.11	-	-	-	-
PB Ratio	0.71	1.04	0.68	1.24	1.35	7.75
P/FCF Ratio	-2.76	-1.43	-0.70	-1.63	-2.49	-36.02
P/OCF Ratio	-2.77	-1.44	-0.70	-1.63	-2.49	-36.07
EV/Sales Ratio	4.06	-7.00	-	-	-	-
EV/EBITDA Ratio	-0.28	0.26	0.10	-0.24	-0.29	-29.73
EV/EBIT Ratio	-0.28	0.26	0.10	-0.23	-0.29	-29.55
EV/FCF Ratio	-0.30	0.33	0.45	-0.23	-0.37	-31.18
Debt / Equity Ratio	-	-	-	0.00	0.00	0.00
Debt / EBITDA Ratio	-	-	-	-0.01	-0.01	-0.02
Debt / FCF Ratio	-	-	-	-0.01	-0.01	-0.02
Quick Ratio	10.93	4.94	8.99	7.25	5.81	14.36
Current Ratio	11.15	5.14	9.42	7.73	6.03	14.68
Asset Turnover	0.04	0.02	0	0	0	0
Return on Equity (ROE)	-56.80%	-65.60%	-750.10%	-63.70%	-56.30%	-77.10%
Return on Assets (ROA)	-46.10%	-52.40%	-291.10%	-54.70%	-49.10%	-28.10%
Return on Capital (ROIC)	-48.40%	-91.26%	-442.18%	-75.35%	-67.94%	-23.68%
Earnings Yield	-61.63%	-81.35%	-642.23%	-60.27%	-51.30%	-2.91%
FCF Yield	-63.73%	-69.87%	-142.58%	-61.17%	-40.13%	-2.78%
Buyback Yield / Dilution	-28.76%	-118.32%	-55.69%	-0.72%	-252.08%	-419.98%
Total Shareholder Return	-28.76%	-118.32%	-55.69%	-0.72%	-252.08%	-419.98%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).